The Ketamine Research Foundation: Clinical Trials

3 trials sponsored by The Ketamine Research Foundation, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 recruiting, 1 unknown. 2 Phase 2, 1 Early Phase 1, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 22Recruiting 1, Unknown 1
Early Phase 11Completed 1
Phase 31Recruiting 1

Follow The Ketamine Research Foundation: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Clinical Trial Exploring the Outpatient Treatment of Phantom Limb Pain With Ketamine Administration in a Six Month Study With a Minimum Remission Period of 7 Days Between Treatment Session. 25-30 Subjects With an Ongoing History of Significant PLP.--FDA and IRB Approved.
IM ketamine in dose finding and then continuation - Phantom Limb Syndrome With Pain
Phase 2 / Phase 3RecruitingThe Ketamine Research Foundation302026-01-152026-03-18
Conscious Dying/Conscious Living: Ketamine-Assisted Psychotherapy
Ketamine Injectable Solution, Naturalistic Control - Illness Terminal
Phase 2UnknownThe Ketamine Research Foundation1202022-05-012022-02-25
The Pharmacokinetics of Ketamine in the Breast Milk of Lactating Women
ketamine in lactation - Ketamine, Lactation
Early Phase 1CompletedThe Ketamine Research Foundation42019-12-202021-12-13

Conditions studied

Breast Feeding (1)  ·  Death (1)  ·  Depression, Postpartum (1)  ·  Pain (1)  ·  Phantom Limb (1)

Interventions

Ketamine (1)  ·  Lactation (1)

Countries

United States (2)

Top investigators

Philip E Wolfson, MD (2)

Results publications

PMID 39260823